Ys Biopharma Co Stock Z Score

YS Stock   0.85  0.04  4.49%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out YS Biopharma Piotroski F Score and YS Biopharma Valuation analysis.
  
At this time, YS Biopharma's Capital Lease Obligations is comparatively stable compared to the past year. Net Invested Capital is likely to gain to about 1.5 B in 2024, whereas Net Working Capital is likely to drop slightly above 281.1 M in 2024. Selling General Administrative is likely to gain to about 87.4 M in 2024, whereas Tax Provision is likely to drop slightly above 969.1 K in 2024.

YS Biopharma Co Company Z Score Analysis

YS Biopharma's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

YS Biopharma Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for YS Biopharma is extremely important. It helps to project a fair market value of YS Biopharma Stock properly, considering its historical fundamentals such as Z Score. Since YS Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of YS Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of YS Biopharma's interrelated accounts and indicators.
0.890.950.92-0.90.980.960.99-0.770.930.970.96-0.610.99-0.820.960.96
0.890.850.8-0.880.890.780.9-0.910.990.920.92-0.490.84-0.90.920.95
0.950.850.89-0.810.880.90.91-0.690.90.910.88-0.730.9-0.910.880.89
0.920.80.89-0.960.860.980.87-0.540.880.820.78-0.820.94-0.840.780.81
-0.9-0.88-0.81-0.96-0.89-0.93-0.890.68-0.93-0.84-0.820.68-0.930.81-0.82-0.86
0.980.890.880.86-0.890.921.0-0.850.920.990.98-0.450.97-0.740.980.98
0.960.780.90.98-0.930.920.93-0.60.850.880.85-0.720.99-0.760.850.86
0.990.90.910.87-0.891.00.93-0.840.930.990.98-0.50.98-0.780.980.98
-0.77-0.91-0.69-0.540.68-0.85-0.6-0.84-0.85-0.89-0.910.11-0.720.67-0.91-0.92
0.930.990.90.88-0.930.920.850.93-0.850.930.92-0.60.9-0.920.920.95
0.970.920.910.82-0.840.990.880.99-0.890.931.0-0.440.94-0.791.01.0
0.960.920.880.78-0.820.980.850.98-0.910.921.0-0.380.92-0.761.01.0
-0.61-0.49-0.73-0.820.68-0.45-0.72-0.50.11-0.6-0.44-0.38-0.610.77-0.38-0.43
0.990.840.90.94-0.930.970.990.98-0.720.90.940.92-0.61-0.760.920.93
-0.82-0.9-0.91-0.840.81-0.74-0.76-0.780.67-0.92-0.79-0.760.77-0.76-0.76-0.8
0.960.920.880.78-0.820.980.850.98-0.910.921.01.0-0.380.92-0.761.0
0.960.950.890.81-0.860.980.860.98-0.920.951.01.0-0.430.93-0.81.0
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

As per the company's disclosures, YS Biopharma Co has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

YS Biopharma Fundamentals

About YS Biopharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:
Check out YS Biopharma Piotroski F Score and YS Biopharma Valuation analysis.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.56)
Revenue Per Share
5.159
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.12)
Return On Equity
(0.62)
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.